JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1476
PUT
Emerson Electric
EMR
$91.2B
| $24.6M | ﹤0.01% |
282,300
-133,600
| -32% | -$11.7M |
2021 Q1
8 quarters
|
|
|
1477
PUT
Automatic Data Processing
ADP
$103B
| $24.5M | ﹤0.01% |
110,100
+74,900
| +213% | +$16.9M |
2021 Q1
8 quarters
|
|
1478
PUT
Monster Beverage
MNST
$85.2B
| $24.5M | ﹤0.01% |
906,400
+32,400
| +4% | +$831K |
2021 Q3
6 quarters
|
|
1479
Columbia Banking Systems
COLB
$8.21B
| $24.5M | ﹤0.01% |
1,141,804
+438,629
| +62% | +$12.2M |
2013 Q2
39 quarters
|
|
1480
Cincinnati Financial
CINF
$25B
| $24.4M | ﹤0.01% |
217,745
+1,765
| +0.8% | +$201K |
2013 Q2
39 quarters
|
|
1481
Vail Resorts
MTN
$4.99B
| $24.4M | ﹤0.01% |
104,332
-13,925
| -12% | -$3.36M |
2015 Q1
32 quarters
|
|
1482
American Financial Group
AFG
$11.7B
| $24.4M | ﹤0.01% |
200,498
+54,912
| +38% | +$7.24M |
2013 Q2
39 quarters
|
|
1483
iShares Core S&P US Value ETF
IUSV
$27.4B
| $24.3M | ﹤0.01% |
329,861
-19,640
| -6% | -$1.45M |
2016 Q1
28 quarters
|
|
1484
Schwab US Large- Cap ETF
SCHX
$75B
| $24.3M | ﹤0.01% |
1,504,203
-152,637
| -9% | -$2.4M |
2018 Q3
18 quarters
|
|
1485
iShares Floating Rate Bond ETF
FLOT
$11.1B
| $24.2M | ﹤0.01% |
480,963
+3,876
| +0.8% | +$196K |
2013 Q2
39 quarters
|
|
1486
Coinbase
COIN
$49B
| $24.1M | ﹤0.01% |
357,102
+238,533
| +201% | +$14.3M |
2021 Q2
7 quarters
|
|
1487
Crane NXT
CXT
$2.86B
| $24.1M | ﹤0.01% |
612,038
+214,336
| +54% | +$8.47M |
2013 Q2
39 quarters
|
|
1488
Phillips Edison & Co
PECO
$4.83B
| $24.1M | ﹤0.01% |
739,169
+110,875
| +18% | +$3.63M |
2021 Q3
6 quarters
|
|
1489
CALL
Palantir
PLTR
$455B
| $24.1M | ﹤0.01% |
2,853,100
+2,786,400
| +4,178% | +$21.8M |
2022 Q3
2 quarters
|
|
|
MPT
1490
Medical Properties Trust
MPT
$1.98B
| $24.1M | ﹤0.01% |
2,931,990
-4,586,679
| -61% | -$50.6M |
2013 Q2
39 quarters
|
|
1491
Affiliated Managers Group
AMG
$9.78B
| $24.1M | ﹤0.01% |
169,151
+11,177
| +7% | +$1.77M |
2013 Q2
39 quarters
|
|
1492
Jones Lang LaSalle
JLL
$13.9B
| $24.1M | ﹤0.01% |
165,569
+15,618
| +10% | +$2.6M |
2013 Q2
39 quarters
|
|
1493
Teleflex
TFX
$5.38B
| $24.1M | ﹤0.01% |
95,002
+10,671
| +13% | +$2.59M |
2013 Q2
39 quarters
|
|
|
APLS
1494
CALL
DELISTED
Apellis Pharmaceuticals
APLS
| $24.1M | ﹤0.01% |
364,700
+360,700
| +9,018% | +$20.8M |
2022 Q3
2 quarters
|
|
1495
Spire
SR
$4.6B
| $24M | ﹤0.01% |
342,485
+23,566
| +7% | +$1.67M |
2013 Q2
39 quarters
|
|
|
SPTN
1496
DELISTED
SpartanNash
SPTN
| $24M | ﹤0.01% |
967,416
+566,957
| +142% | +$16.3M |
2013 Q2
39 quarters
|
|
1497
Coupang
CPNG
$25.5B
| $23.9M | ﹤0.01% |
1,496,251
-113,013
| -7% | -$1.75M |
2021 Q1
8 quarters
|
|
1498
Ormat Technologies
ORA
$5.61B
| $23.9M | ﹤0.01% |
281,840
+132,682
| +89% | +$11.6M |
2014 Q4
33 quarters
|
|
1499
PUT
Abbott
ABT
$174B
| $23.9M | ﹤0.01% |
235,900
+155,900
| +195% | +$16.5M |
2017 Q3
22 quarters
|
|
1500
H&R Block
HRB
$5.18B
| $23.9M | ﹤0.01% |
676,978
+53,054
| +9% | +$1.96M |
2013 Q2
39 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.